Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
|Slideshows|August 21, 2018
- Drug Topics November 2018
- Volume 163
- Issue 11
The Top 10 Best States to Be a Pharmacist
Author(s)Robert Elsenpeter
Our annual look at the best states to practice pharmacy, based on everything from salary to robbery statistics.
Advertisement
Articles in this issue
almost 8 years ago
Opinion: Pharmacists Are More Than Just Drug Expertsalmost 8 years ago
Simple Communication Techniques Can Increase Patient Comprehensionalmost 8 years ago
7 Tips for Becoming a Better Manageralmost 8 years ago
Methods for Elderly Medication Managementalmost 8 years ago
Prescription Counseling Equally Applicable to THC Productsalmost 8 years ago
Small Doses: November Newsalmost 8 years ago
Boost Pharmacy RevenueAdvertisement
Related to this article
The trial found that up to 25 days of nirmatrelvir-ritonavir did not improve cognitive, autonomic, or exercise-related symptoms compared with placebo.
Digital innovation and proactive patient care are converging to transform clinical practice while preserving essential safeguards.
James Barnes, CPhT, explains why respecting a patient's time isn't about speed and how he landed in the pharmacy by chance.
ACIP changes, new court rulings, and coverage gaps threaten vaccines, pharmacists’ reimbursement, and children's access through Vaccine For Children.
As pouched products increase in popularity, researchers assess their pharmacology, harm-reduction potential, and initiation risk.
The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.
Adults with serious mental illness receive GLP-1 prescriptions at rates similar to or higher than their peers, though schizophrenia continued to lag.
Advertisement
Advertisement
Trending on Drug Topics
1
Nicotine Pouches Create Opportunity for Pharmacist Counseling
2
Worth a Shot: How ACIP Changes Might Impact Vaccine Access, Coverage
3
FDA Approves Finerenone for Chronic Kidney Disease With Type 1 Diabetes
4
GLP-1 Prescribing Rose Among Adults With Serious Mental Illness
5